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The cytokinesis-block micronucleus (CBMN) assay is one of the standard cytogenetic tools employed to assess chromosomal
damage subsequent to exposure to genotoxic/cytotoxic agents, and is widely applicable to plant, animal and human cells. In the
present study, the CBMN assay was used to assess the baseline damage in binuclear human peripheral blood lymphocytes
exposed to 25 µg/L p,p’-DDT for 1, 2, 24, and 48 h by measuring the frequency of micronuclei, nucleoplasmic bridges and nuclear
buds. These new scoring criteria facilitated the detection of different types of clastogenic and aneugenic effects induced by this
type of pollutant. With these criteria, CBMN can also be used to measure nucleoplasmic bridges which are considered to be
consequences of chromosome rearrangements and nuclear buds which are biomarkers of altered gene amplification and gene
dosage. The total number of micronuclei observed in binuclear human peripheral blood lymphocytes of the exposed samples
(ranging from 32 to 47) was significantly greater (P < 0.05) than that detected in the unexposed (0 time) control sample, where
the total number of micronuclei was 7. The number of nucleoplasmic bridges and nuclear buds obtained after 24 and 48 h was
also significantly (P < 0.05) greater in the samples treated with p,p’-DDT than in the unexposed control samples. Thus, our results
confirmed the usefulness of the new criteria applicable for the CBMN assay employed in measuring the DNA damage and its role
of a sensitive cytogenetic biomarker.
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Over the last decade, the wide applicability of the in
vitro micronucleus test in peripheral blood lymphocytes
and the simplicity of scoring have made it an attractive
cytogenetic tool to assess occupational and environmen-
tal exposures to genotoxic agents. The formation of micro-
nuclei is considered to be an effective biomarker of dis-
eases and processes associated with DNA damage. The
cytokinesis-block micronucleus (CBMN) assay solved the
problem of variations in micronucleus frequency caused
by the alterations in the proportion of dividing cells that
may occur when cells are exposed to genotoxic agents, by
restricting the scoring of micronuclei to once-divided cells
(1). Except for cytogenetic damage measured by the num-
ber and distribution of micronuclei, according to the new
criteria for micronuclei scoring, the CBMN assay also
detects the nucleoplasmic bridges, as well as nuclear
buds. Current evidence suggests that nucleoplasmic
bridges derive from dicentric chromosomes in which the
centromeres have been pulled to the opposite poles of the
cell during the anaphase stage, and are therefore indica-
tive of the DNA mis-repair, chromosome rearrangement or
telomere end-fusion. According to the new criteria appli-
cable to the CBMN assay, nuclear buds arise from the
elimination of the amplified DNA and possibly from the
elimination of the DNA-repair complexes, which therefore,
may be considered a marker of gene amplification and
altered gene dosage. In this respect, the micronucleus
assay has evolved into a comprehensive method em-
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ployed in measuring chromosomal instability of the pheno-
type and altered cell viability and represents an effective
tool to be used in research of cellular and nuclear dysfunc-
tions caused by in vitro or in vivo exposure to toxic sub-
stances (2,3). The present study reports the results ob-
tained with the CBMN assay, measuring the frequency of
micronuclei, nucleoplasmic bridges and nuclear buds in
binuclear human lymphocytes exposed to a very low con-
centration of p,p’-DDT.
Dichlorodiphenyltrichloroethane (DDT) is a pesticide
that was once extensively used to control insects affecting
agricultural crops, and those carrying various diseases
such as malaria and typhus; however, it is now used in only
a small number of countries to control malaria. Technical-
grade DDT (1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane)
is a mixture of three forms, p,p’-DDT (85%), o,p’-DDT
(15%) and o,o’-DDT (trace amounts), but may also contain
DDE (1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene) and
DDD (1,1-dichloro-2,2-bis(p-chlorophenyl)ethane) as con-
taminants; both are breakdown products of DDT (4). In the
most developed countries, DDT and DDT-based products
were prohibited for use as pesticides in the 1970s and
1980s, because of their persistence, bioaccumulation and
carcinogenicity (5). However, in other countries in which
malaria is a long-standing public health problem, DDT is
still the main pesticide used for mosquito control. Much
research shows that DDT affects nervous, reproductive,
and immunological systems and can provoke several types
of cancer (6-9). DDT and its metabolites have also been
tested in numerous genotoxicity studies conducted in ani-
mals and bacterial systems, but the number of studies on
humans is insufficient (10-12). Mean blood concentration
of DDT in humans ranges from 27.1 µg/L in children up to
67.8 µg/L in adults (12). Considering the lack of data on the
effect of DDT on the cellular genome, and taking into
account its usage in some countries of the Third World and
its environmental persistence, the aim of this study was to
assess the genotoxic potential of a low concentration of
aqueous (25 µg/L) p,p’-DDT upon in vitro exposure of
human peripheral blood lymphocytes of different duration,
by using the new criteria for scoring micronucleus assay
measuring the frequency of micronuclei, nucleoplasmic
bridges and nuclear buds.
Peripheral blood samples were obtained from a healthy
25-year-old female donor. Blood was collected by veni-
puncture and stored in heparinized tubes (Becton Dickin-
son, NJ, USA). Blood was subsequently divided into aliquots
and sored at 4°C. All experiments were conducted on
peripheral blood lymphocytes cultivated in Euroclone me-
dium (Sigma, USA) at 37°C in the presence of phytohe-
magglutinin.
The DDT metabolite was administered in the form of
p,p’-DDT (Sulpeco, USA). Just before the beginning of the
experiment, p,p’-DDT was dissolved in saline buffer at
25°C and added to the lymphocyte cultures at a final
concentration of 25 µg/L for 0 (control), 1, 2, 24, and 48 h.
Micronucleus assay was performed in agreement with
the guidelines described by Fenech et al. (13,14). Accord-
ing to the new scoring criteria, not only distribution of
micronuclei, but also the frequency of nucleoplasmic
bridges and nuclear buds were scored (1-3,15). Cytocha-
lasine-B (Sigma) at a final concentration of 3 µg/mL was
added 44 h after culture initiation. The cultures were har-
vested at 72 h. The lymphocytes were fixed in methanol-
acetic acid solution (3:1), air-dried and stained with 5%
Giemsa solution (Sigma). One thousand binuclear lym-
phocytes were analyzed on duplicate slides (difference
below 2%) for the evaluation of micronuclei incidence and
their distribution per micronuclear cells, as well as nucleo-
plasmic bridges and nuclear buds. The total number and
distribution of micronuclei, nucleoplasmic bridges and nu-
clear buds scored in binucleated cells were evaluated
using the chi-square test.
Table 1 summarizes the frequency and distribution of
Table 1. Total number and distribution of micronuclei, nucleoplasmic bridges and nuclear buds in peripheral
blood samples exposed to 25 µg/L p,p’-DDT for 1, 2, 24, or 48 h.
Exposure time (h) Number of binuclear lymphocytes Total Nucleoplasmic Nuclear
to p,p’-DDT micronuclei bridges buds
0 MN 1 MN 2 MN 3 MN
Control 993 7 0 0 7 3 0
1 971* 26* 3 0 32* 4 7
2 961* 36* 3 0 42* 5 8
24 958* 38* 3 1 47* 14* 10*
48 959* 37* 3 1 46* 18* 22*
The incidence of micronuclei was evaluated by analyzing 1000 cells. MN = micronucleus.
*P < 0.05 greater than the corresponding unexposed control (chi-square test).
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micronuclei, nucleoplasmic bridges and nuclear buds in
the exposed and control groups. The total number of
micronuclei observed in binuclear peripheral blood lym-
phocytes of the exposed samples (ranging from 32 to 47)
was significantly (P < 0.05) greater than that detected in
the unexposed (0 time) control sample, where the total
number of micronuclei was 7. At 24 and 48 h, the number
of nucleoplasmic bridges (ranging from 10 to 22) and
nuclear buds (ranging from 14 to 18) were also significantly
(P < 0.05) greater in samples treated with p,p’-DDT than in
the unexposed control (ranging from 0 to 3). The p,p’-DDT
treatment caused primary DNA damage as opposed to
untreated control lymphocytes.
Due to its uncontrolled use during the last half of the
20th century, DDT, probably the best known and most
used insecticide in the world, has induced changes in both
working and living environments, and may cause adverse
effects on human health. Even though its use has been
prohibited in most countries on the basis of ecological
considerations and its negative impact on wildlife, it is still
used in some developing countries in an attempt to control
malaria. Thus, it can still pose a health risk for humans,
even in countries that banned its use 30 years ago (4,5).
Genotoxic studies of DDT are mainly based on investi-
gations on animal models, and its genotoxicity has been
evaluated using standard cytogenetic techniques. Re-
search results obtained by the investigation of cytogenetic
effects of DDT presented in the mouse spleen indicate that
DDT induces a statistically significant increase in chromo-
somal aberrations at a dose of 5.5 mg/kg after a 24-h
exposure (16). The results obtained in humans under in
vitro exposure of peripheral blood indicated that the corre-
lation between DDT dose and the number of cells contain-
ing chromosomal aberrations is non-existent. However,
when the Poisson test was used for comparison, the per-
centage of cells containing structural aberrations was sig-
nificantly higher at certain DDT concentrations (0.20, 4.05
and 8.72 µg/mL) than in controls (9). There is also a report
on the biomonitoring of populations occupationally and
environmentally exposed to DDT, among which a positive
correlation between the frequency of cells containing chro-
mosomal aberrations and DDT plasma levels, as well as
exposure time, had been found. Interestingly, direct or
indirect contact with DDT was not always in correlation
with the degree of contamination (11).
The results of the present study of the effect of DDT on
the incidence of micronuclei are in agreement with the
earlier observation (17). They indicated that, after expo-
sure to p,p’-DDT at concentrations of 10 and 15 µg/mL,
skin fibroblast culture of the Arctic beluga whale (Delphina-
pterus leucas) exhibits statistically significant increases in
micronuclei, ranging from 1.7- to 5-fold compared to con-
trols (17). However, there are no data about the micro-
nucleus assay performed in human cells exposed to p,p’-
DDT under in vitro conditions.
The present study reports the results of the frequen-
cies of micronuclei, nucleoplasmic bridges and nuclear
buds observed in cultured human lymphocytes treated
with a very low concentration of p,p’-DDT, scored accord-
ing to the criteria proposed by the HUMN project (15).
Based on the results of the present study, it is clear that
modified micronucleus assay is more sensitive to DNA
damage than other cytogenetic methods and, as such, did
show a statistically significant (P < 0.05) increase in the
number of micronuclei, nucleoplasmic bridges and nuclear
buds. These new criteria now indicate that this method can
also be used to measure nucleoplasmic bridges, which are
considered to be a biomarker of dicentric chromosomes
resulting from telomere end-fusions or DNA mis-repair.
This method is also capable of measuring nuclear buds,
which are a biomarker able to detect gene amplification
and altered gene dosage events by virtue of providing a
measure for the extent of chromosome rearrangement
which is otherwise not measured in this assay in case only
micronuclei are scored (2,3,18,19).
Undoubtedly, the current results confirm the value of
the CBMN assay as a sensitive endpoint that will have to
be further evaluated and standardized for the assessment
of micronuclei frequencies, nucleoplasmic bridges and
nuclear buds, employed in comparing genetic damage
caused by different mutagens under in vitro and in vivo
conditions.
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